Short Interest in Artemis Therapeutics Inc. (OTCMKTS:ATMS) Decreases By 18.2%
Short Interest in Artemis Therapeutics Inc. (OTCMKTS:ATMS) Decreases By 18.2%
Artemis Therapeutics Inc. (OTCMKTS:ATMS – Get Rating) was the target of a significant decline in short interest during the month of September. As of September 15th, there was short interest totalling 900 shares, a decline of 18.2% from the August 31st total of 1,100 shares. Based on an average daily trading volume, of 1,200 shares, the short-interest ratio is presently 0.8 days.
Artemis Therapeutics Stock Performance
Shares of Artemis Therapeutics stock traded up $0.30 on Friday, hitting $3.00. 5,022 shares of the company's stock traded hands, compared to its average volume of 1,159. The firm's 50-day moving average price is $1.81 and its two-hundred day moving average price is $2.26. Artemis Therapeutics has a one year low of $0.55 and a one year high of $5.00.
Get Artemis Therapeutics alerts:About Artemis Therapeutics
(Get Rating)
Artemis Therapeutics Inc does not have significant operations. Previously, it was involved in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company is based in New York, New York. Artemis Therapeutics Inc is a subsidiary of Tonak Ltd.Read More
- Get a free copy of the StockNews.com research report on Artemis Therapeutics (ATMS)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Declining Profits Challenge the CarMax Value Proposition
- Thor Industries Hammers Out A Bottom
Receive News & Ratings for Artemis Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Artemis Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
Artemis Therapeutics Inc. (OTCMKTS:ATMS – Get Rating) was the target of a significant decline in short interest during the month of September. As of September 15th, there was short interest totalling 900 shares, a decline of 18.2% from the August 31st total of 1,100 shares. Based on an average daily trading volume, of 1,200 shares, the short-interest ratio is presently 0.8 days.
Artemis治療公司(場外交易市場代碼：ATMS-GET Rating)是空頭股數9月份顯著下降的目標。截至9月15日，空頭股數共有900股，比8月31日的1100股下降了18.2%。以日均成交量1,200股計算，目前短息比為0.8天。
Artemis Therapeutics Stock Performance
Artemis治療公司股票表現
Shares of Artemis Therapeutics stock traded up $0.30 on Friday, hitting $3.00. 5,022 shares of the company's stock traded hands, compared to its average volume of 1,159. The firm's 50-day moving average price is $1.81 and its two-hundred day moving average price is $2.26. Artemis Therapeutics has a one year low of $0.55 and a one year high of $5.00.
Artemis治療公司的股票週五上漲0.30美元，達到3.00美元。該公司股票有5,022股易手，而其平均成交量為1,159股。該公司的50日移動均線價格為1.81美元，200日移動均線價格為2.26美元。Artemis Treeutics的一年低點為0.55美元，一年高位為5.00美元。
About Artemis Therapeutics
關於Artemis Treateutics
(Get Rating)
(獲取評級)
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on Artemis Therapeutics (ATMS)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Declining Profits Challenge the CarMax Value Proposition
- Thor Industries Hammers Out A Bottom
- 免費獲取StockNews.com關於Artemis治療(ATMS)的研究報告
- 電動汽車電池製造商Freyr將在全球大舉擴張
- MarketBeat：回顧一週9/26-9/30
- 這是買入美光科技的難忘時刻
- 利潤下降對CarMax價值主張的挑戰
- 雷神工業走出谷底
Receive News & Ratings for Artemis Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Artemis Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
接受Artemis治療日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Artemis治療公司和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧